Let's see what's new in the market
Thermo Fisher Scientific Announces Collaboration to Develop Highly Sensitive Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring
Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows.
Through the detection of disease-related antigens directly from patient blood samples, NanoPin's unique diagnostic platform using Thermo Fisher's advanced LC-MS technology will lead to the development of sensitive clinical assays for infectious disease. This will enable healthcare providers to reduce time to results, determine infection stage and monitor patient response to prescribed treatment. The quantified information gleaned from the combined technology will support clinical decision-making and the provision of personalized patient care unique to their disease state.
Bruker Introduces Updated B.I.QUANT-UR Module for Fully Validated Metabolite Quantification in Urine using NMR
Bruker today announces the release of the B.I.QUANT-UR™ module, the only analysis solution on the market that complies with DIN-ISO criteria for the identification and quantification of urine metabolites on Bruker’s nuclear magnetic resonance (NMR) in-vitro diagnostic research (Avance™IVDr) platforms. The module automatically quantifies up to 150 endogenous and disease-related metabolites from urine, allowing users to obtain precise, sensitive and fully reproducible results, even below the limit of detection (LOD).
China chooses the Sterilwave solution developed by BertinTechnologies with assistance from CNIM Industrial Systems China for on-site treatment of waste contaminated by the coronavirus in hospitals in Wuhan region.
In February 2020, the Chinese Minister of Health confirmed the acquisition of 16 Sterilwave treatment stations for the main hospitals in the Wuhan region. These ultra-compact, innovative systems with proven efficiency in terms of viral inactivation make it possible to treat biomedical waste that has potentially been contaminated by the coronavirus (2019-nCoV) directly on site and consequently eliminate all risk of contamination outside the hospital. Thanks toSterilwavesolutions, the dangerous waste generated by hospitals is no longer taken by truck from the hospital to distant treatment sites, which significantly limits the risk of contagion.
EPPAC (Protective Equipment for Fighter Aircraft Pilot) qualified by the DGA: The first systems will be delivered during the first half of 2020
The EPPAC system, CBRN protection system intended for French fighter pilots, was officially qualified by the DGA (Direction Générale de l’Armement) in September 2019. The EPPAC system was designed and produced by Ouvry, under the supervision of work of the DGA and in connection with the Center of military air expertise [CEAM] of Mont-de-Marsan. It is notably composed of different innovative elements protecting against chemical agents: underwear worn under flight clothing and ventilated hood worn under the helmet, providing comfort in extreme conditions, reliability and adaptability. Ouvry will provide the MCO (Maintenance in operational condition).
Following the qualification, the DGA notified, on December 11th 2019, the first production tranche of the new CBRN protective equipment for fighter jet pilot.